COVID-19 RESPONSE

Click here to read about our efforts to help address the crisis.

Listen to our March 2nd presentation at the Cowen 40th Annual Health Care Conference by clicking here.

Click here to read about our collaboration with the University of Alabama at Birmingham.

OUR PIPELINE

Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B (HepTcellTM), and conjugated immunostimulants for the treatment of cancer (ALT-702). In addition, we are developing intranasal vaccine programs for anthrax, influenza and COVID-19.

LIVER THERAPIES

CANCER

INTRANASAL VACCINES